In primary breast cancer, an analysis of molecular subtypes demonstrated that TP53 mutations were more frequent in HER2+ and TNBC breast cancer than in other subtypes (p<0.05, Figure 2B). The gene discussed is ERBB2; the disease is breast cancer.